Combined immunotherapy employing Wilms' tumor 1 peptide‐pulsed dendritic cells and hormone or chemotherapeutic agents in patients with metastatic castration resistant prostate cancer

Authors

Masahiro Ogasawara (ORCID: https://orcid.org/0000-0002-7919-7146)
Shuichi Ota (ORCID: https://orcid.org/0000-0002-3631-244X)
Mamiko Miyashita
Yuka Yamagishi

Institutions

Sapporo Hokuyu Hospital (JP)

Publication Details

Journal: Therapeutic Apheresis and Dialysis
Published: 2025-04-13
DOI: https://doi.org/10.1111/1744-9987.70016
Primary Topic: Immunotherapy and Immune Responses
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Combined immunotherapy employing Wilms' tumor 1 peptide‐pulsed dendritic cells and hormone or chemotherapeutic agents in patients with metastatic castration resistant prostate cancer

Masahiro Ogasawara, Shuichi Ota, Mamiko Miyashita, Yuka Yamagishi

Apr 13, 2025

1 links

Therapeutic Apheresis and Dialysis

Immunotherapy and Immune Responses

article

Combined immunotherapy employing Wilms' tumor 1 peptide‐pulsed dendritic cells and hormone or chemotherapeutic agents in patients with metastatic castration resistant prostate cancer

Masahiro Ogasawara, Shuichi Ota, Mamiko Miyashita, Yuka Yamagishi

April 13, 2025article en

Abstract

No abstract available for this paper.

Therapeutic Apheresis and DialysisVol. 29(4)

Sapporo Hokuyu Hospital (JP)

Good health and well-being

Openalex Percentile: Top 92%

Immunotherapy and Immune Responses

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Combined immunotherapy employing Wilms' tumor 1 peptide‐pulsed dendritic cells and hormone or chemotherapeutic agents in patients with metastatic castration resistant prostate cancer — Masahiro Ogasawara, Shuichi Ota, et al. · Therapeutic Apheresis and Dialysis (2025) | TGRS Research Map | TGRS